Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells

Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells

US Patent 7504211 · Granted Mar 17, 2009

Estimated economic value: $62,161,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of 2025
Directionally assembled flexible MOF hydrogel, and preparation method and proton2025
Methods of treating myelodysplastic syndrome2025
Built-in multi-zone fast evenly mixed sampling device of SCR outlet flue2024
Human genetic markers associated with response to treatments that target clostri2024
Anti-human MSLN antibody and MSLN-targeting immune effector cell2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2023
Genetic polymorphisms associated with cardiovascular disorders and drug response2023
Conjugation reagents and methods using 1,2-cyclohexanediones2023
Polymers containing furanyl crosslinkable groups and uses thereof2022
Combination treatment for hematological cancers2022